Synthego, a leading genome engineering solutions company, today announced the launch of the Gene Knockout Kit v2. This is the only product that leverages a novel bioinformatics- powered multi-guide ...
Elmar Nurmemmedov, Principal Investigator and Director of Drug Discovery at Saint John’s Cancer Institute (CA, USA), explains how CRISPR is used in drug discovery and how artificial intelligence can ...
Synthego’s CEO and co-founder Paul Dabrowski used to be lead digital designer at SpaceX. Now that he’s applying his engineering talents to intracellular space, he hopes to contribute to dramatic cost ...
As a fast and easy-to-use gene-editing technique, CRISPR is one of the biggest discoveries in 21 st century medical science, and an important facilitator of gene therapy development. Several gene ...
SAN DIEGO--(BUSINESS WIRE)--On October 26 th 2022, CRISPR QC has announced that Toby Richardson, PhD has been appointed to the board of directors. CRISPR QC has already started proving that the unique ...
A single-dose CRISPR-CasRx nanotherapy targeting a host enzyme reduces SARS-CoV-2 viral load and promotes alveolar repair in a hamster model of long COVID, offering a promising strategy for treating ...
Researchers at InBio (formerly Indoor Biotechnologies), a biotech company in Virginia, report progress en route to developing a hypoallergenic cat – or at least treating patients with allergies to the ...
The HIRI researchers involved in the study; from left: Sandra Gawlitt, Lars Barquist, Chase Beisel, Yanying Yu. Copyright: Helmholtz Institute for RNA-based Infection ...
DCx addresses the root drivers of cancer, genetic mutations that lead to tumor proliferation and survival, by deconvoluting key cellular interdependencies using the MuSic™ platform. Understanding this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback